Cargando…

Multi-level immune response network in mild-moderate Chronic Obstructive Pulmonary Disease (COPD)

BACKGROUND: Chronic Obstructive Pulmonary Disease (COPD) is associated with an abnormal pulmonary and systemic immune response to tobacco smoking. Yet, how do immune cells relate within and between these two biological compartments, how the pulmonary infiltrate influences the lung transcriptome, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cruz, Tamara, López-Giraldo, Alejandra, Noell, Guillaume, Casas-Recasens, Sandra, Garcia, Tamara, Molins, Laureano, Juan, Manel, Fernandez, Marco A., Agustí, Alvar, Faner, Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626346/ https://www.ncbi.nlm.nih.gov/pubmed/31299954 http://dx.doi.org/10.1186/s12931-019-1105-z

Ejemplares similares

Characterization, localization and comparison of c-Kit+ lung cells in never smokers and smokers with and without COPD
por: López-Giraldo, Alejandra, et al.
Publicado: (2018)

Molecular Interactions of SARS-CoV-2 in Lung Tissue of Patients with Chronic Obstructive Pulmonary Disease
por: Agusti, Alvar, et al.
Publicado: (2021)

Do sputum or circulating blood samples reflect the pulmonary transcriptomic differences of COPD patients? A multi-tissue transcriptomic network META-analysis
por: Faner, Rosa, et al.
Publicado: (2019)

From systems biology to P4 medicine: applications in respiratory medicine
por: Noell, Guillaume, et al.
Publicado: (2018)

Telomere Length but Not Mitochondrial DNA Copy Number Is Altered in Both Young and Old COPD
por: Casas-Recasens, Sandra, et al.
Publicado: (2021)

Lung immune signatures define two groups of end-stage IPF patients
por: Cruz, Tamara, et al.
Publicado: (2023)

Systemic Inflammatory Response to Smoking in Chronic Obstructive Pulmonary Disease: Evidence of a Gender Effect
por: Faner, Rosa, et al.
Publicado: (2014)

The inflammasome pathway in stable COPD and acute exacerbations
por: Faner, Rosa, et al.
Publicado: (2016)

When Harry Met Sally, or When Machine Learning Met Chronic Obstructive Pulmonary Disease
por: Agusti, Alvar, et al.
Publicado: (2020)

The EASI model: A first integrative computational approximation to the natural history of COPD
por: Agustí, Alvar, et al.
Publicado: (2017)

Bone marrow characterization in COPD: a multi-level network analysis
por: Toledo-Pons, Nuria, et al.
Publicado: (2018)

Blood Immunophenotypes of Idiopathic Pulmonary Fibrosis: Relationship with Disease Severity and Progression
por: Mendoza, Nuria, et al.
Publicado: (2023)

An investigation of the resolution of inflammation (catabasis) in COPD
por: Noguera, Aina, et al.
Publicado: (2012)

SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae
por: Cruz, Tamara, et al.
Publicado: (2022)

Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19
por: Agusti, Alvar, et al.
Publicado: (2021)

Network medicine analysis of COPD multimorbidities
por: Grosdidier, Solène, et al.
Publicado: (2014)

Liver epigenome changes in patients with hepatopulmonary syndrome: A pilot study
por: Mendoza, Nuria, et al.
Publicado: (2021)

Persistence of a SARS-CoV-2 T-cell response in patients with long COVID and lung sequelae after COVID-19
por: Cruz, Tamara, et al.
Publicado: (2023)

Reply to Guo et al.
por: Wang, Gang, et al.
Publicado: (2023)

Natural history of COPD: gaps and opportunities
por: Agustí, Alvar, et al.
Publicado: (2017)

COPD: time to improve its taxonomy?
por: Celli, Bartolomé R., et al.
Publicado: (2018)

Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled Studies
por: Wedzicha, Jadwiga A., et al.
Publicado: (2016)

Estudio histológico mediante biopsia pulmonar post mortem en pacientes con neumonía por COVID-19
por: Sellarés, Jacobo, et al.
Publicado: (2022)

[Translated article] Histology Study of Postmortem Lung Biopsies in Patients With Covid-19 Pneumonia
por: Sellarés, Jacobo, et al.
Publicado: (2022)

Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?
por: Halpin, David M G, et al.
Publicado: (2020)

Cellular Senescence in Lung Fibrosis
por: Hernandez-Gonzalez, Fernanda, et al.
Publicado: (2021)

COPD & COVID-19
por: Halpin, David M.G., et al.
Publicado: (2021)

COPD & COVID-19
por: Halpin, David M.G., et al.
Publicado: (2021)

The Overlap of Lung Tissue Transcriptome of Smoke Exposed Mice with Human Smoking and COPD
por: Obeidat, Ma’en, et al.
Publicado: (2018)

Dyspnoea and symptom burden in mild–moderate COPD: the Canadian Cohort Obstructive Lung Disease Study
por: Cherian, Mathew, et al.
Publicado: (2021)

Highlights and hot topics in the management of COPD: where are we heading?
por: Agustí, Alvar, et al.
Publicado: (2016)

Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge
por: Sibila, Oriol, et al.
Publicado: (2022)

Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD
por: Johnson, Kate M, et al.
Publicado: (2018)

Factors associated with exacerbation in mild- to-moderate COPD patients
por: Kim, Joo Kyung, et al.
Publicado: (2016)

Inhaled corticosteroids for the treatment of COVID-19
por: Bafadhel, Mona, et al.
Publicado: (2022)

Chronic obstructive pulmonary disease (COPD) in Spain and the different aspects of its social impact: a multidisciplinary opinion document
por: Bouza, Emilio, et al.
Publicado: (2020)

Reduced airway levels of fatty-acid binding protein 4 in COPD: relationship with airway infection and disease severity
por: Perea, Lídia, et al.
Publicado: (2020)

Alterations in Serum Polyunsaturated Fatty Acids and Eicosanoids in Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)
por: Titz, Bjoern, et al.
Publicado: (2016)

Arginines Plasma Concentration and Oxidative Stress in Mild to Moderate COPD
por: Zinellu, Angelo, et al.
Publicado: (2016)

What have we learned from observational studies and clinical trials of mild to moderate COPD?
por: Barrecheguren, Miriam, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ofk7p3ig825ft3ehhiu514h561